ArticleNature communications2022

Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia.

Earl Sands et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.